Sana Biotechnology
SANA
SANA
201 hedge funds and large institutions have $648M invested in Sana Biotechnology in 2025 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 67 increasing their positions, 48 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11% more capital invested
Capital invested by funds: $582M → $648M (+$66.4M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9.11% less ownership
Funds ownership: 68.85% → 59.74% (-9.1%)
Holders
201
Holding in Top 10
3
Calls
$3.54M
Puts
$1.15M
Top Buyers
| 1 | +$13.4M | |
| 2 | +$7.52M | |
| 3 | +$6.15M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.94M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$4.48M |
Top Sellers
| 1 | -$29.3M | |
| 2 | -$21.6M | |
| 3 | -$7.7M | |
| 4 |
JP Morgan Chase
New York
|
-$5.91M |
| 5 |
Millennium Management
New York
|
-$4.46M |
